Xspray Pharma AB's market cap is currently €98.79M. The company's EPS TTM is €-0.10781365500000001; its P/E ratio is ―; Xspray Pharma AB is scheduled to report earnings on August 15, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
